Vivendi, FR0000127771

Sanofi Stock - weekly review and pharma sector comparison

19.06.2026 - 21:22:13 | ad-hoc-news.de

Sanofi stock closes out the week with a muted performance while the wider European pharma sector also trades sideways. This weekly review looks at how Sanofi stacks up against key peers and where the consensus now stands on earnings and pipeline drivers.

Vivendi, FR0000127771
Vivendi, FR0000127771

Edited by ad hoc news Sector & Peer-Group Desk. Verified prior to publication on 06/19/2026, 19:21 UTC. Details in the imprint.

Sanofi (FR0000127771) ends the week with a calm trading pattern, broadly in line with other large European pharma names. With no fresh company-specific headlines from major wires or the investor relations page, attention shifts to how the stock compares with peers over the past five sessions.

Go deeper

All news and background on Sanofi stock

Further regulatory filings, earnings material and historical articles on Sanofi are available via our topic hub and the company's investor relations site.

How Sanofi fared this week

Over the past five trading days, Sanofi shares have moved broadly in line with the European blue-chip healthcare cohort, with only modest day-to-day swings and no outsized reaction to macro data or sector news.

Sector indices tracking European pharmaceuticals and biotechnology also showed muted performance on the week, reflecting a lack of major regulatory or earnings catalysts for the group.

Position in the pharma peer group

In terms of market capitalization, Sanofi ranks among the larger European drug makers alongside companies such as Novo Nordisk, Roche and Novartis, giving it a prominent weight in regional healthcare benchmarks followed by institutional investors.

Against this backdrop, the stock often trades as a proxy for European defensive growth, and weekly flows in healthcare-focused funds can therefore have a visible impact on Sanofi's relative performance versus the wider market.

How the company makes money

Sanofi generates most of its revenue from patented prescription medicines, vaccines and consumer healthcare products, with key franchises in areas such as immunology, rare diseases, vaccines and diabetes, complemented by a significant R&D pipeline.

Where the stock trades today

The shares of Sanofi (FR0000127771) trade on Euronext Paris at EUR 88.50 as of 06/19/2026, 17:35 CET.

Key facts on Sanofi stock

  • Company: Sanofi S.A.
  • ISIN: FR0000127771
  • WKN: 920657
  • Ticker: SAN
  • Venue: Euronext Paris
  • Price (as of 06/19/2026, 17:35 CET): 88.50 EUR
  • Market cap: 112,000,000,000 EUR (as of 06/19/2026)
  • Sector / Industry: Health Care / Pharmaceuticals
  • Index membership: CAC 40
  • Next earnings date: not officially scheduled

More on Sanofi stock on social media

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.

en | FR0000127771 | VIVENDI | boerse | 69585340 | bgmi